ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 13.98
+1.68 (13.66%)
Sep 5, 2025, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 5.69 billion as of September 5, 2025. Its market cap has increased by 64.53% in one year.
Market Cap
5.69B
Enterprise Value
5.09B
Revenue
134.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.98
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 5.69B, a decrease of -21.84%. That is a compound annual growth rate of -11.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 5.69B | 170.93% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.19B |
| Hansoh Pharmaceutical Group Company | 224.72B |
| JD Health International | 204.41B |
| Innovent Biologics | 176.58B |
| Sino Biopharmaceutical | 159.35B |
| WuXi Biologics | 150.75B |
| Akeso | 142.50B |
| CSPC Pharmaceutical Group | 127.94B |